Profile data is unavailable for this security.
About the company
Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
- Revenue in USD (TTM)299.52m
- Net income in USD-77.33m
- Incorporated2014
- Employees1.03k
- LocationTabula Rasa HealthCare Inc228 Strawbridge DriveMOORESTOWN 08057United StatesUSA
- Websitehttp://www.tabularasahealthcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yoshitsu Co Ltd (ADR) | 228.44m | 3.27m | 34.80m | 54.00 | 9.59 | 0.78 | 7.72 | 0.1523 | 0.1001 | 0.1001 | 7.59 | 1.23 | 1.93 | 6.60 | 5.17 | -- | 2.77 | -- | 6.53 | -- | 17.10 | -- | 1.43 | -- | 1.27 | 3.14 | 0.5812 | -- | 3.12 | -- | -40.74 | -- | -- | -- |
Homology Medicines Inc | 3.21m | -5.01m | 54.62m | 92.00 | -- | 0.3059 | 30.69 | 17.03 | -0.0992 | -0.0992 | 0.0558 | 3.10 | 0.0146 | -- | -- | 34,869.57 | 0.2195 | -31.22 | 0.2413 | -33.71 | -- | -- | 15.06 | -818.17 | -- | -- | 0.00 | -- | -90.56 | -- | 94.77 | -- | -8.08 | -- |
China Jo-Jo Drugstores Holdings Inc | 158.63m | -3.52m | 89.81m | 911.00 | -- | 1.01 | -- | 0.5662 | -0.9731 | -0.9731 | 39.59 | 4.36 | 1.45 | 6.96 | 9.90 | 174,127.50 | -3.22 | -8.29 | -9.51 | -23.55 | 23.98 | 22.07 | -2.22 | -5.89 | 0.7688 | -- | 0.5619 | -- | 23.48 | 15.07 | 60.69 | -- | -5.73 | -- |
Rite Aid Corp | 24.06bn | -897.69m | 122.09m | 53.00k | -- | -- | -- | 0.0051 | -16.50 | -16.50 | 441.76 | -7.14 | 2.72 | 9.80 | 14.50 | 454,045.10 | -10.14 | -3.96 | -15.04 | -5.77 | 19.93 | 21.12 | -3.73 | -1.58 | 0.6009 | 0.3473 | 1.14 | -- | 2.18 | 1.39 | -438.10 | -- | -5.56 | -- |
Marimed Inc | 134.01m | 13.47m | 135.22m | 592.00 | 6.29 | 2.25 | 7.16 | 1.01 | 0.063 | 0.063 | 0.426 | 0.289 | 0.9732 | 4.79 | 46.03 | 226,368.30 | 9.89 | -16.39 | 12.11 | -22.22 | 47.73 | 51.69 | 10.16 | -19.66 | 0.9313 | 31.09 | 0.2425 | -- | 10.33 | 85.70 | 86.42 | -- | -9.49 | -- |
Tabula Rasa HealthCare Inc | 299.52m | -77.33m | 139.73m | 1.03k | -- | -- | -- | 0.4665 | -3.18 | -6.09 | 12.34 | -2.10 | 0.678 | 38.73 | 7.37 | 291,641.70 | -17.50 | -12.88 | -21.86 | -15.31 | 22.34 | 28.68 | -25.82 | -20.93 | 1.60 | -5.98 | 1.22 | -- | 15.25 | 17.54 | -48.04 | -- | 34.14 | -- |
Petmed Express Inc | 260.45m | 11.40m | 335.24m | 212.00 | 28.35 | 2.51 | 22.90 | 1.29 | 0.5609 | 0.5609 | 12.82 | 6.34 | 1.56 | 7.49 | 162.23 | 1,228,552.00 | 6.84 | 19.33 | 8.26 | 23.28 | 28.04 | 31.07 | 4.38 | 10.54 | 3.59 | -- | 0.00 | 72.36 | -11.58 | 1.87 | -31.05 | -2.40 | -30.24 | 9.57 |
Holder | Shares | % Held |
---|---|---|
Indaba Capital Management LPas of 31 Dec 2022 | 6.52m | 24.04% |
Apo Asset Management GmbHas of 28 Feb 2023 | 1.33m | 4.90% |
UBS Securities LLCas of 31 Dec 2022 | 1.30m | 4.80% |
The Vanguard Group, Inc.as of 31 Dec 2022 | 1.19m | 4.37% |
Kennedy Capital Management, Inc.as of 31 Dec 2022 | 971.74k | 3.58% |
Baillie Gifford & Co.as of 31 Dec 2022 | 831.69k | 3.07% |
Repertoire Partners LPas of 31 Dec 2022 | 549.80k | 2.03% |
Jacobs Levy Equity Management, Inc.as of 31 Dec 2022 | 478.16k | 1.76% |
BlackRock Fund Advisorsas of 31 Dec 2022 | 438.47k | 1.62% |
Fuller & Thaler Asset Management, Inc.as of 31 Dec 2022 | 351.94k | 1.30% |